Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia-Reference-Cited by-同舟云学术

Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia

Published:2013-03 Issue: Volume:66 Page:158-169
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Bennouar Khaled-Ezaheir,Uberti Michelle A.,Melon Christophe,Bacolod Maria D.,Jimenez Hermogenes N.,Cajina Manuel,Kerkerian-Le Goff Lydia,Doller Darío,Gubellini Paolo

Funder

Aix-Marseille Université

Centre National de la Recherche Scientifique

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference68 articles.

1. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov. Disord.,2001

2. The functional anatomy of basal ganglia disorders;Albin;Trends Neurosci.,1989

3. Synaptic dysfunction in Parkinson's disease;Bagetta;Biochem. Soc. Trans.,2010

4. Effects of GPi and STN inactivation on physiological, motor, cognitive and motivational processes in animal models of Parkinson's disease;Baunez;Prog. Brain Res.,2010

5. Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental Parkinsonism;Beurrier;FASEB J.,2009

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Insights in Positron Emission Tomography Tracers for Metabotropic Glutamate Receptor 4 Imaging;Journal of Medicinal Chemistry;2024-06-26

2. Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia;Journal of Parkinson's Disease;2024-03-05

3. Ion Channels and Metal Ions in Parkinson’s Disease: Historical Perspective to the Current Scenario;Methods in Molecular Biology;2024

4. Targeting mGluR group III for the treatment of neurodegenerative diseases;Biomedicine & Pharmacotherapy;2023-12

5. Foliglurax, a positive allosteric modulator of the metabotrophic glutamate receptor 4, protects dopaminergic neurons in MPTP-lesioned male mice;Brain Research;2023-06